Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-19-002053

VP, Clinical&Translational Sc gave up 1,498 shares (to pay taxes)

  • VP, Clinical&Translational Sc acquired 5,079 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DeVinney Erick Wayne VP, Clinical&Translational Sc 2019-02-15 Grant or award +5,079 43,469 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2019-02-15 Shares withheld for taxes −1,498 $17.57 $26,320 41,971 D
Loading xslF345X03/edgar.xml…